Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Two likely scenarios: New permanent rules are finalized before the extension expires, establishing clear pathways for telemedicine prescribing of controlled substances (probably requiring special registration or state-matching) Another extension is granted while rules are still being developed (this has happened four times already) What you should do now: Build your practice around non-controlled medications (GLP-1s) as the foundation If using controlled substances (phentermine), have a backup plan: either transition patients to in-person visits for medication management or switch to non-controlled alternatives Monitor DEA proposed rulemaking (watch for Federal Register notices in 2026) Join professional associations that lobby for permanent telehealth access (APA, AMA, AANP) Is there higher regulatory risk with telehealth weight-loss prescribing
Final Thoughts: The Best GLP-1 Receptor Agonist for Rapid Weight Loss Choosing the best GLP-1 for weight loss depends on your health, goals, and medical history
10.2337/dc16-0126 145
In a population of coronary patients, data from our laboratory indicated a huge increased all-cause crude mortality over a mean 7.7-year follow-up in diabetics on combined treatment with metformin and glibenclamide
A tissue biopsy confirmed colonic ischemia
US$ 22.51
US$ 23.38
US$ 21.53
US$ 20.03
